Hema Now: Scaling Precision Medicine in Blood Cancer Care

In this episode of Hema Now, Anna Schuh discusses the evolution of precision medicine in haematology. From her early inspiration to pursue haematology to her pioneering work in chronic lymphocytic leukaemia, she reflects on how whole genome sequencing, single-cell technologies, and circulating tumour DNA are transforming risk prediction and treatment strategies. Timestamps: 00:00 – Introduction 02:20 – What drew Anna to haematology 03:57 – Chronic lymphocytic leukaemia 08:55 – Genomics reshaping high risk chronic lymphocytic leukaemia 12:19 – OxPLoreD and STELLAR aims 15:52 – Liquid biopsies 19:56 – Global diagnostics implementation challenges 25:57 – Integrating molecular testing clinically 29:20 – Training future precision leaders 33:51 – Next breakthroughs in precision haematology 35:35 – Three magic wishes